APOE Genotype and Cognitive Decline in Older Adults
Author Information
Author(s): Helen Christensen, Philip J Batterham, Andrew J Mackinnon, Anthony F Jorm, Holly A Mack, Karen A Mather, Kaarin J Anstey, Perminder S Sachdev, Simon Easteal
Primary Institution: The Australian National University
Hypothesis
The rate of cognitive decline over four years from ages 65 to 69 would be greater for APOE *E4 carriers.
Conclusion
APOE *E4 carriers may experience greater cognitive decline in the presence of other risk factors at ages 65 to 69.
Supporting Evidence
- APOE *E4 carriers showed poorer performance on cognitive tests compared to non-carriers.
- Cognitive decline was more pronounced in *E4 carriers when controlling for risk factors like head injury and education.
- The study included a large community sample, enhancing the generalizability of the findings.
Takeaway
People with a specific gene called APOE *E4 might have more trouble with thinking and memory as they get older, especially if they have other health issues.
Methodology
A four-year follow-up study examining cognitive performance in 2021 individuals aged 65-69, focusing on the effects of APOE genotype and various risk factors.
Potential Biases
Potential biases due to the exclusion of non-Caucasian participants and those not genotyped.
Limitations
The study had a relatively short follow-up period and modest power to detect interaction effects.
Participant Demographics
Participants were aged 65-69, with a gender breakdown of 1,319 men and 1,232 women.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website